Interaction of insulin and PPAR-α genes in Alzheimer's disease: The Epistasis Project

Journal of Neural Transmission

Volumn 119, Issue 4, 2012, Pages 473-479

  Kölsch, Heike ^a   Lehmann, Donald J ^b   Ibrahim Verbaas, Carla A ^c   Combarros, Onofre ^d   Van Duijn, Cornelia M ^c   Hammond, Naomi ^e   Belbin, Olivia ^f   Cortina Borja, Mario ^g   Lehmann, Michael G ^b   Aulchenko, Yurii S ^c   Schuur, Maaike ^c   Breteler, Monique ^c   Wilcock, Gordon K ^h   Brown, Kristelle ^f   Kehoe, Patrick G ⁱ   Barber, Rachel ⁱ   Coto, Eliecer ^j   Alvarez, Victoria ^j   Deloukas, Panos ^e   Mateo, Ignacio ^d   Maier, Wolfgang ^a   Morgan, Kevin ^f   Warden, Donald R ^b   Smith, A David ^b   Heun, Reinhard ^a,k   more..

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^k ROYAL DERBY HOSPITAL   (United Kingdom)

more..

Author keywords

Alzheimer's disease; Glucose metabolism; Heterosis; Insulin; Peroxisome proliferator activated receptor alpha

Indexed keywords

INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPISTASIS; FEMALE; GENE FREQUENCY; GENOTYPE; HORMONE PROTEIN COMPLEX; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; EPISTASIS, GENETIC; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR ALPHA;

EID: 84863450316     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0732-4     Document Type: Article

References (39)

1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17-23
2. Brune S, Kölsch H, Ptok U, Majores M, Schulz A, Schlosser R, Rao ML, Maier W, Heun R (2003) Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease. J Neural Transm 110:1041-1050
3. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Mastroianni F, Liaci M, Vendemiale G, Capurso A, Panza F (2005) The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations. J Gerontol A Biol Sci Med Sci 60:991-996
4. Combarros O, Van Duijn CM, Hammond N, Belbin O, Arias-Vásquez A, Cortina-Borja M, Lehmann MG, Aulchenko YS, Schuur M, Kölsch H, Heun R, Wilcock GK, Brown K, Kehoe PG, Harrison R, Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Morgan K, Warden DR, Smith AD, Lehmann DJ (2009) Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J Neuroinflamm 6:22
5. Combarros O, Warden DR, Hammond N, Cortina-Borja M, Belbin O, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Barber R, Coto E, Alvarez V, Deloukas P, Gwilliam R, Heun R, Kolsch H, Mateo I, Oulhaj A, Arias-Vasquez A, Schuur M, Aulchenko YS, Ikram MA, Breteler MM, Van Duijn CM, Morgan K, Smith AD, Lehmann DJ (2010) The dopamine beta-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med Genet 11:162
6. Combs CK, Bates P, Karlo JC, Landreth GE (2001) Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem Int 39:449-457
7. Comings DE, MacMurray JP (2000) Molecular heterosis: a review. Mol Genet Metab 71:19-31
8. Cortina-Borja M, Smith AD, Combarros O, Lehmann DJ (2009) The synergy factor: a statistic to measure interactions in complex diseases. BMC Res Notes 2:105
9. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease-relationship to severity of dementia and apolipoprotein E genotype. Neurology 50:164-168
10. De laMonte SM, Wands JR (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis 9:167-181
11. Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688
12. Escher P, Wahli W (2000) Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448:121-138
13. Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA (2001) A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med 79:198-204
14. Flavell DM, Pineda TI, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller G, Talmud PJ, Staels B, Humphries SE (2000) Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia 43:673-680
15. Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvanne M (2002) Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 105:1440-1445
16. Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105:423-438
17. Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B (2000) Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275:16638-16642
18. Harold D, Abraham R,Hollingworth P, Sims R, GerrishA,HamshereML, Pahwa JS,Moskvina V, DowzellK,WilliamsAet al (2009) Genomewide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41:1088-1093
19. Hofman A, Breteler MM, Van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC (2007) The Rotterdam Study: objectives and design update. Eur J Epidemiol 22:819-829
20. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V et al (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43:429-435
21. Hoyer S (2002) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm 109:341-360
22. Hoyer S (2003) Memory function and brain glucose metabolism. Pharmacopsychiatry 36(Suppl 1):S62-S67
23. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421-424
24. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, Van Duijn CM, Kehoe PG (2005) Large metaanalysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 162:305-317
25. Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, Kölsch H, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Morris CM, Barker R, Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Combarros O, Arias-Vásquez A, Aulchenko YS, Ikram MA, Breteler MM, Van Duijn CM, Oulhaj A, Heun R, Cortina-Borja M, Morgan K, Robson K, Smith AD (2010) Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol Aging [Epub ahead of print]
26. Majores M, Kölsch H, Bagli M, Ptok U, Kockler M, Becker K, Rao ML, Maier W, Heun R (2002) The insulin gene VNTR polymorphism in Alzheimer's disease: results of a pilot study. J Neural Transm 109:1029-1034
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
28. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ (2000) Geography of HFE C282Y and H63D mutations. Genet Test 4:183-198
29. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
30. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
31. Roduit R, Morin J, Masse F, Segall L, Roche E, Newgard CB, Assimacopoulos-Jeannet F, Prentki M (2000) Glucose down-regulates the expression of the peroxisome proliferator-activated receptoralpha gene in the pancreatic beta-cell. JBiolChem275:35799-35806
32. Sandhu MS, Heude B, Young EH, Luben R, Luan J, Khaw KT, Todd J, Wareham NJ (2005) INS VNTR class genotype and indexes of body size and obesity: population-based studies of 7,999 middleaged men and women. Diabetes 54:2812-2815
33. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA (1996) The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137:4499-4502
34. Swaab DF, Lucassen PJ, Salehi A, Scherder EJ, van Someren EJ, Verwer RW (1998) Reduced neuronal activity and reactivation in Alzheimer's disease. Prog Brain Res 117:343-377
35. Vafiadis P, Ounissi-Benkalha H, Palumbo M, Grabs R, Rousseau M, Goodyer CG, Polychronakos C (2001) Class III alleles of the variable number of tandem repeat insulin polymorphism associated with silencing of thymic insulin predispose to type 1 diabetes. J Clin Endocrinol Metab 86:3705-3710
36. Vohl MC, Lepage P, Gaudet D, Brewer CG, Betard C, Perron P, Houde G, Cellier C, Faith JM, Despres JP, Morgan K, Hudson TJ (2000) Molecular scanning of the human PPARa gene: association of the L162V mutation with hyperapobetalipoproteinemia. J Lipid Res 41:945-952
37. Vu-Hong TA, Durand E, Deghmoun S, Boutin P, Meyre D, Chevenne D, Czernichow P, Froguel P, Levy-Marchal C (2006) The INS VNTR locus does not associate with smallness for gestational age (SGA) but interacts with SGA to increase insulin resistance in young adults. J Clin Endocrinol Metab 91:2437-2440
38. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565-1572
39. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK (1995) Structural organization of mouse peroxisome proliferatoractivated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci USA 92:7921-7925